Halozyme Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
Amgen USD 20.48B 2.53B 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Cytokinetics USD 131.06M 28.66M 2025-06
DBV Technologies USD 49.42M 9.04M 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Halozyme Therapeutics USD 134.28M 16.1M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
MannKind USD 111.83M 4.11M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06


Halozyme Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.